Clinical Trial Update: Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing safety and biological effects of an eicosapentaenoic acid–enriched oil in individuals with heart disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Drugs mentioned

• EPA-enriched oil (eicosapentaenoic acid-enriched oil)

Snippet

Sponsor: Cardiovascular Research Associates | Conditions: Heart Disease | Phase 1 | Status: COMPLETED